AQST

Aquestive Therapeutics (AQST)

Aquestive Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AQST

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/14	02:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/05/14	02:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/05/09	21:00	GlobeNewswire Inc.	Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/05/08	05:23	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/05/08	05:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/05/08	05:19	GlobeNewswire Inc.	Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/04/29	20:00	GlobeNewswire Inc.	Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/04/25	21:00	GlobeNewswire Inc.	Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/04/13	05:01	GlobeNewswire Inc.	Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/04/01	21:00	GlobeNewswire Inc.	Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/25	21:00	GlobeNewswire Inc.	Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/20	10:49	GlobeNewswire Inc.	Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/20	05:01	GlobeNewswire Inc.	Aquestive Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/15	06:23	GlobeNewswire Inc.	Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/11	23:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/11	23:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/11	23:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/11	23:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/11	23:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/11	23:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/11	23:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/09	06:14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/06	07:12	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/06	07:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/03/06	07:05	GlobeNewswire Inc.	Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/02/21	22:00	GlobeNewswire Inc.	Aquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/02/15	22:00	GlobeNewswire Inc.	Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data at the 2024 AAAAI Annual Meeting	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/02/15	05:24	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/02/13	07:02	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:AQST	Aquestive Therapeutics Inc
2024/01/30	22:00	GlobeNewswire Inc.	Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference	NASDAQ:AQST	Aquestive Therapeutics Inc